f-chemotactic peptide has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graeff, H; Hafter, R; Jänicke, F; Kanayama, N; Schmitt, M | 1 |
| Kanayama, N; Terao, T | 1 |
2 other study(ies) available for f-chemotactic peptide and Breast Neoplasms
| Article | Year |
|---|---|
Human tumor cell urokinase-type plasminogen activator (uPA): degradation of the proenzyme form (pro-uPA) by granulocyte elastase prevents subsequent activation by plasmin.
Topics: Breast Neoplasms; Chemotactic Factors; Cytochalasin B; Endopeptidases; Enzyme Activation; Enzyme Precursors; Fibrinolysin; Granulocytes; Humans; Immunohistochemistry; Oligopeptides; Pancreatic Elastase; Thrombin; Urokinase-Type Plasminogen Activator | 1991 |
Inactivation of human tumor cell pro-urokinase by granulocyte elastase.
Topics: Breast Neoplasms; Chemotactic Factors; Enzyme Activation; Female; Fibrinolysis; Granulocytes; Humans; Oligopeptides; Pancreatic Elastase; Plasminogen Activators; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator; Uterine Cervical Neoplasms; Uterine Neoplasms | 1990 |